Eikon Therapeutics and Veradermics have gone public, with other biotechs poised to stage IPOs.

Agomab Therapeutics NV (Nasdaq: AGMB) ('Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an ...

The company's IPO comes as shoppers and policymakers alike have pushed back on ultra-processed foods.

The National Stock Exchange of India (NSE) on Friday announced that its governing board has formally approved plans to launch ...

AIA, J.P. Morgan Asset Management and International Finance Corp are among the companies vying for shares in the Malaysian ...

The National Stock Exchange (NSE) has received approval from its governing board to undertake its Initial Public Offering ...

Foraker and Garner got involved with Once Upon a Time after discovering the baby food brand launched by Cassandra Curtis and Ari Raz. The brand's focus on fresh and organic ingredients appealed to ...

It comes at a time when the Thai stock exchange is grappling with the departure of companies. Read more at straitstimes.com.

SEBI clears eight IPOs, including InCred Holdings, Ardee Industries, and Shankesh Jewellers, while Mann Fleet Partners ...

Biopol Chemicals launched its IPO on February 6, offering 28,94,400 shares priced between ₹102 and ₹108. The IPO closes on ...

InCred Holdings has secured SEBI approval for its IPO and will announce issue details such as price band and dates closer to ...

Agomab Therapeutics NV (Nasdaq: AGMB) ("Agomab"), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies ...